| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |